Goldman Sachs
BMEA icon

Goldman Sachs’s Biomea Fusion BMEA Stock Holding History

Goldman Sachs’s Portfolio BMEA Stock Details BMEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-41,900
Closed -$577K – 5631
2023
Q3 		$577K Hold
41,900
– – ﹤0.01% 4589
2023
Q2 		$920K Buy
+41,900
New +$1.31M ﹤0.01% 4397

Other funds holding BMEA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Goldman Sachs's BMEA Position: Q2 2026 in Review

Goldman Sachs increased its Biomea Fusion (BMEA) stake by 24% in Q2 2026, buying an estimated $26.9K and bringing the position to 93,757 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #6293.

Goldman Sachs first reported a position in BMEA in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.2M in Q1 2024. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Goldman Sachs held 93,757 shares of Biomea Fusion worth $138K as of Q2 2026.
  • Goldman Sachs bought 18,018 Biomea Fusion shares in Q2 2026, an estimated $26.9K.
  • Biomea Fusion made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6293 holding.
  • Goldman Sachs first reported a position in Biomea Fusion in Q4 2021 and has held it in 19 quarters since.
  • Goldman Sachs's Biomea Fusion position peaked at $5.2M in Q1 2024.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.